Hypothetical model linking multiple biological pathways in the development of SS-like disease based on differentially expressed genes identified in lacrimal glands by global microarray analyses
A hypothetical model linking multiple biological pathways in the development of SS-like disease based on differentially expressed genes identified in lacrimal glands by global microarray analyses. Starting with 27 genes identified as differentially expressed, a model for cellular dysfunction, initiation of inflammation, and altered antigen presentation has been designed that forms a basis for lacrimal gland pathology in SS. This model focuses considerable attention on reduced antigen-presentation by dendritic cells and macrophages in favor of B-cell antigen presentation considered more likely to result in autoimmune responses. Microarray data shows that transcripts for retinoic acid receptors RXR-α and RAR, as well as prostaglandin-α-activated PPAR-γ, are highly downregulated. These factors help regulate fatty acid, lipoprotein, and cholesterol homeostasis within cells and tissues, plus differentiation of DC; therefore, we hypothesize that an imbalance in the retinoic acid pathway leading to fatty acid, lipoprotein, and cholesterol dysregulation results in DC populations in NOD and C57BL/6.NOD-Aec1Aec2 mice that exhibit reduced responses to CSF, as previously reported.At the same time, there is apparently dysregulation in the interaction of the cathepsins and cystatins, especially the regulation of cathepsin-S by cystatin-C. Cystatin-C is a major inhibitor of the cathepsin-S in macrophages and DC. Gene expression of cathepsin-S indicates that it is highly upregulated during the early phases of disease development, but unlike the other cathepsins, eg, cathepsin-B, which is down-regulated, its expression remains elevated as the SS-like disease progresses. Since cathepsin-S (and IL-6) remains resistant to regulation by cystatin-C, we suggest that the levels of this protein become too high in the lysosomes, resulting in the breakdown of the MHC-class II binding with the invariant chain, CD74. This is known to prevent proper loading of the MHC-class II molecules with antigen for proper presentation by macrophages and DC, thereby permitting increased antigen presentation by B-cells, increasing the chance for autoimmunity. In contrast, cathepsin-B is strongly downregulated, and this results in the increased expression of multiple genes, eg, cathepsin-H, metallothionein, β-2-microglobulin, C1q, fibronectin and apolipoprotein-D.While each of these factors can play an important role in the onset and propagation of inflammation,, fibronectin is involved in multiple pathways. In addition to promoting association of integrins with transmembrane proteins (encoded by Tmem), thereby influencing cell migration, fibronectin can bind to collagen type-1α1 and α2 (precursors of the more prominent collagen of the eye) with subsequent activation of Raf1, a molecule that is highly pro-apoptotic.
Publication
Unraveling the Pathophysiology of Sjogren Syndrome-Associated Dry Eye Disease. () Cuong Q. Nguyen, et al. Ocul Surf. ;7(1):11-27. Figure: F3.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | IL-6 | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Homo sapiens | Primates | IL-4 | IL-4 | ncbigene_synonym | IL4 | 3565 |
| Homo sapiens | Primates | Raf1 | RAF1 | ncbigene_symbol | RAF1 | 5894 |
| Homo sapiens | Primates | Raf1 | RAF1 | ncbigene_synonym | RNASE3 | 6037 |
| Homo sapiens | Primates | Stat3 | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | Stat6 | STAT6 | ncbigene_symbol | STAT6 | 6778 |
| Homo sapiens | Primates | Colla2 | COL1A2 | ncbigene_symbol | COL1A2 | 1278 |
| Homo sapiens | Primates | CXCL12 | CXCL12 | ncbigene_symbol | CXCL12 | 6387 |
| Homo sapiens | Primates | MMP-3 | MMP-3 | ncbigene_synonym | MMP3 | 4314 |
| Homo sapiens | Primates | Ctss | CTSS | ncbigene_symbol | CTSS | 1520 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNK | 56832 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNW1 | 3467 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA1 | 3439 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA2 | 3440 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA4 | 3441 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA5 | 3442 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA6 | 3443 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA7 | 3444 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA8 | 3445 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA10 | 3446 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA13 | 3447 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA14 | 3448 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA16 | 3449 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA17 | 3451 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNA21 | 3452 |
| Homo sapiens | Primates | Interferon- | INTERFERON | famplex_relations | IFNB1 | 3456 |
| Homo sapiens | Primates | MMP-2 | MMP-2 | ncbigene_synonym | MMP2 | 4313 |
| Homo sapiens | Primates | MMP-9 | MMP-9 | ncbigene_synonym | MMP9 | 4318 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1A | 4489 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1B | 4490 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1E | 4493 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1F | 4494 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1G | 4495 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1H | 4496 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1JP | 4498 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1M | 4499 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1L | 4500 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1X | 4501 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MTNR1A | 4543 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | ALG1 | 56052 |
| Homo sapiens | Primates | Mt1/2-Zn** | MT1 | ncbigene_synonym | MT1IP | 644314 |
| Homo sapiens | Primates | B2M | B2M | ncbigene_symbol | B2M | 567 |
| Homo sapiens | Primates | CtsH | CTSH | ncbigene_symbol | CTSH | 1512 |
| Homo sapiens | Primates | Cts | CTS | ncbigene_synonym | TTR | 7276 |
| Homo sapiens | Primates | C5a | C5A | ncbigene_synonym | C5 | 727 |
| Homo sapiens | Primates | C5a | C5A | ncbigene_synonym | C5AR1 | 728 |
| Homo sapiens | Primates | ApoD | APOD | ncbigene_symbol | APOD | 347 |
| Homo sapiens | Primates | PLA2 | PLA2 | ncbigene_synonym | PLA2G1B | 5319 |
| Homo sapiens | Primates | PLA2 | PLA2 | ncbigene_synonym | PLA2G2A | 5320 |
| Homo sapiens | Primates | PLA2 | PLA2 | ncbigene_synonym | PLA2G6 | 8398 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G3 | 50487 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G5 | 5322 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G7 | 7941 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G10 | 8399 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G12A | 81579 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G12B | 84647 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2C | 391013 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2D | 26279 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2E | 30814 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G2F | 64600 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G4A | 5321 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G4C | 8605 |
| Homo sapiens | Primates | PLA2 | PLA2 | famplex_relations | PLA2G4D | 283748 |
| Homo sapiens | Primates | PAF-AH | PAFAH | ncbigene_synonym | PAFAH1B1 | 5048 |
| Homo sapiens | Primates | PAF | PAF | ncbigene_synonym | PCLAF | 9768 |
| Homo sapiens | Primates | ApoE | APOE | ncbigene_symbol | APOE | 348 |
| Homo sapiens | Primates | Stat1 | STAT1 | ncbigene_symbol | STAT1 | 6772 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| Arachidonic acid | NA | mesh:D001095 | ||
| Cholesteryl esters | Cholesterol Esters | mesh:D002788 | cholesteryl ester | chebi:17002 |
| Prostaglandins | prostaglandin | mesh:D011453 | Prostaglandins | chebi:26333 |
| Leukotrienes | Leukotrienes | mesh:D015289 | leukotriene | chebi:25029 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|